“Lebrikizumab Improves Atopic Dermatitis in Adult and Adolescent Patients With Skin of Color: 16-Week Results From the ADmirable Study” (2025) SKIN The Journal of Cutaneous Medicine, 9(1), p. s515. doi:10.25251/skin.9.supp.515.